2022-10-012023-12-312023-12-31false08357958MEDISHOUT LTD2024-07-1061900iso4217:GBPxbrli:pure083579582022-10-01083579582023-12-31083579582022-10-012023-12-31083579582022-01-01083579582022-09-30083579582022-01-012022-09-3008357958bus:SmallEntities2022-10-012023-12-3108357958bus:AuditExempt-NoAccountantsReport2022-10-012023-12-3108357958bus:FullAccounts2022-10-012023-12-3108357958bus:PrivateLimitedCompanyLtd2022-10-012023-12-3108357958core:WithinOneYear2023-12-3108357958core:AfterOneYear2023-12-3108357958core:WithinOneYear2022-09-3008357958core:AfterOneYear2022-09-3008357958core:ShareCapital2023-12-3108357958core:SharePremium2023-12-3108357958core:RevaluationReserve2023-12-3108357958core:OtherReservesSubtotal2023-12-3108357958core:RetainedEarningsAccumulatedLosses2023-12-3108357958core:ShareCapital2022-09-3008357958core:SharePremium2022-09-3008357958core:RevaluationReserve2022-09-3008357958core:OtherReservesSubtotal2022-09-3008357958core:RetainedEarningsAccumulatedLosses2022-09-3008357958core:LandBuildings2023-12-3108357958core:PlantMachinery2023-12-3108357958core:Vehicles2023-12-3108357958core:FurnitureFittings2023-12-3108357958core:OfficeEquipment2023-12-3108357958core:NetGoodwill2023-12-3108357958core:IntangibleAssetsOtherThanGoodwill2023-12-3108357958core:ListedExchangeTraded2023-12-3108357958core:UnlistedNon-exchangeTraded2023-12-3108357958core:LandBuildings2022-09-3008357958core:PlantMachinery2022-09-3008357958core:Vehicles2022-09-3008357958core:FurnitureFittings2022-09-3008357958core:OfficeEquipment2022-09-3008357958core:NetGoodwill2022-09-3008357958core:IntangibleAssetsOtherThanGoodwill2022-09-3008357958core:ListedExchangeTraded2022-09-3008357958core:UnlistedNon-exchangeTraded2022-09-3008357958core:LandBuildings2022-10-012023-12-3108357958core:PlantMachinery2022-10-012023-12-3108357958core:Vehicles2022-10-012023-12-3108357958core:FurnitureFittings2022-10-012023-12-3108357958core:OfficeEquipment2022-10-012023-12-3108357958core:NetGoodwill2022-10-012023-12-3108357958core:IntangibleAssetsOtherThanGoodwill2022-10-012023-12-3108357958core:ListedExchangeTraded2022-10-012023-12-3108357958core:UnlistedNon-exchangeTraded2022-10-012023-12-3108357958core:MoreThanFiveYears2022-10-012023-12-3108357958core:Non-currentFinancialInstruments2023-12-3108357958core:Non-currentFinancialInstruments2022-09-3008357958dpl:CostSales2022-10-012023-12-3108357958dpl:DistributionCosts2022-10-012023-12-3108357958core:LandBuildings2022-10-012023-12-3108357958core:PlantMachinery2022-10-012023-12-3108357958core:Vehicles2022-10-012023-12-3108357958core:FurnitureFittings2022-10-012023-12-3108357958core:OfficeEquipment2022-10-012023-12-3108357958dpl:AdministrativeExpenses2022-10-012023-12-3108357958core:NetGoodwill2022-10-012023-12-3108357958core:IntangibleAssetsOtherThanGoodwill2022-10-012023-12-3108357958dpl:GroupUndertakings2022-10-012023-12-3108357958dpl:ParticipatingInterests2022-10-012023-12-3108357958dpl:GroupUndertakingscore:ListedExchangeTraded2022-10-012023-12-3108357958core:ListedExchangeTraded2022-10-012023-12-3108357958dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2022-10-012023-12-3108357958core:UnlistedNon-exchangeTraded2022-10-012023-12-3108357958dpl:CostSales2022-01-012022-09-3008357958dpl:DistributionCosts2022-01-012022-09-3008357958core:LandBuildings2022-01-012022-09-3008357958core:PlantMachinery2022-01-012022-09-3008357958core:Vehicles2022-01-012022-09-3008357958core:FurnitureFittings2022-01-012022-09-3008357958core:OfficeEquipment2022-01-012022-09-3008357958dpl:AdministrativeExpenses2022-01-012022-09-3008357958core:NetGoodwill2022-01-012022-09-3008357958core:IntangibleAssetsOtherThanGoodwill2022-01-012022-09-3008357958dpl:GroupUndertakings2022-01-012022-09-3008357958dpl:ParticipatingInterests2022-01-012022-09-3008357958dpl:GroupUndertakingscore:ListedExchangeTraded2022-01-012022-09-3008357958core:ListedExchangeTraded2022-01-012022-09-3008357958dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2022-01-012022-09-3008357958core:UnlistedNon-exchangeTraded2022-01-012022-09-3008357958core:NetGoodwill2023-12-3108357958core:IntangibleAssetsOtherThanGoodwill2023-12-3108357958core:LandBuildings2023-12-3108357958core:PlantMachinery2023-12-3108357958core:Vehicles2023-12-3108357958core:FurnitureFittings2023-12-3108357958core:OfficeEquipment2023-12-3108357958core:AfterOneYear2023-12-3108357958core:WithinOneYear2023-12-3108357958core:ListedExchangeTraded2023-12-3108357958core:UnlistedNon-exchangeTraded2023-12-3108357958core:ShareCapital2023-12-3108357958core:SharePremium2023-12-3108357958core:RevaluationReserve2023-12-3108357958core:OtherReservesSubtotal2023-12-3108357958core:RetainedEarningsAccumulatedLosses2023-12-3108357958core:NetGoodwill2022-09-3008357958core:IntangibleAssetsOtherThanGoodwill2022-09-3008357958core:LandBuildings2022-09-3008357958core:PlantMachinery2022-09-3008357958core:Vehicles2022-09-3008357958core:FurnitureFittings2022-09-3008357958core:OfficeEquipment2022-09-3008357958core:AfterOneYear2022-09-3008357958core:WithinOneYear2022-09-3008357958core:ListedExchangeTraded2022-09-3008357958core:UnlistedNon-exchangeTraded2022-09-3008357958core:ShareCapital2022-09-3008357958core:SharePremium2022-09-3008357958core:RevaluationReserve2022-09-3008357958core:OtherReservesSubtotal2022-09-3008357958core:RetainedEarningsAccumulatedLosses2022-09-3008357958core:NetGoodwill2022-01-0108357958core:IntangibleAssetsOtherThanGoodwill2022-01-0108357958core:LandBuildings2022-01-0108357958core:PlantMachinery2022-01-0108357958core:Vehicles2022-01-0108357958core:FurnitureFittings2022-01-0108357958core:OfficeEquipment2022-01-0108357958core:AfterOneYear2022-01-0108357958core:WithinOneYear2022-01-0108357958core:ListedExchangeTraded2022-01-0108357958core:UnlistedNon-exchangeTraded2022-01-0108357958core:ShareCapital2022-01-0108357958core:SharePremium2022-01-0108357958core:RevaluationReserve2022-01-0108357958core:OtherReservesSubtotal2022-01-0108357958core:RetainedEarningsAccumulatedLosses2022-01-0108357958core:AfterOneYear2022-10-012023-12-3108357958core:WithinOneYear2022-10-012023-12-3108357958core:Non-currentFinancialInstrumentscore:CostValuation2022-10-012023-12-3108357958core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2022-10-012023-12-3108357958core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2022-10-012023-12-3108357958core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2022-10-012023-12-3108357958core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2022-10-012023-12-3108357958core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2022-10-012023-12-3108357958core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2022-10-012023-12-3108357958core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2022-10-012023-12-3108357958core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2022-10-012023-12-3108357958core:Non-currentFinancialInstrumentscore:CostValuation2023-12-3108357958core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-12-3108357958core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-12-3108357958core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-12-3108357958core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-12-3108357958core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-12-3108357958core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-12-3108357958core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-12-3108357958core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-12-3108357958core:Non-currentFinancialInstrumentscore:CostValuation2022-09-3008357958core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2022-09-3008357958core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2022-09-3008357958core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2022-09-3008357958core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2022-09-3008357958core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2022-09-3008357958core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2022-09-3008357958core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2022-09-3008357958core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2022-09-3008357958bus:Director12022-10-012023-12-3108357958bus:Director22022-10-012023-12-3108357958bus:Director32022-10-012023-12-3108357958bus:Director42022-10-012023-12-3108357958bus:Director52022-10-012023-12-31

MEDISHOUT LTD

Registered Number
08357958
(England and Wales)

Unaudited Financial Statements for the Period ended
31 December 2023

MEDISHOUT LTD
Company Information
for the period from 1 October 2022 to 31 December 2023

Directors

BAHSOUN, Ali Nehme
GIBBS, Keith George
KALRAIYA, Ashish Jain, Dr
MURDOCH, Simon Thomas, Dr
SHAH, Saavan

Registered Address

2 Sherrock Gardens
Hendon
London
NW4 4JJ

Registered Number

08357958 (England and Wales)
MEDISHOUT LTD
Balance Sheet as at
31 December 2023

Notes

31 Dec 2023

30 Sep 2022

£

£

£

£

Fixed assets
Tangible assets313,2094,118
13,2094,118
Current assets
Debtors15,11457,597
Cash at bank and on hand2,644,769543,016
2,659,883600,613
Creditors amounts falling due within one year4(100,903)(59,610)
Net current assets (liabilities)2,558,980541,003
Total assets less current liabilities2,572,189545,121
Creditors amounts falling due after one year5-(300,000)
Net assets2,572,189245,121
Capital and reserves
Called up share capital22
Share premium5,467,0001,166,999
Profit and loss account(2,894,813)(921,880)
Shareholders' funds2,572,189245,121
The financial statements were approved and authorised for issue by the Board of Directors on 10 July 2024, and are signed on its behalf by:
KALRAIYA, Ashish Jain, Dr
Director
Registered Company No. 08357958
MEDISHOUT LTD
Notes to the Financial Statements
for the period ended 31 December 2023

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
The financial statements have been prepared in accordance with the Companies Act 2006 and FRS 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland including Section 1A Small Entities.
Revenue from sale of goods
Revenue from the sale of goods is recognised when the company has transferred to the buyer the significant risks and rewards of ownership of the goods, usually when goods are delivered and legal title has passed. Providing the amount of revenue can be measured reliably, it is probable that the economic benefits associated with the transaction will flow to the company and the costs incurred or to be incurred in respect of the transition can be measured reliably.
Employee benefits
Short-term employee benefits are measured at the undiscounted amount expected to be paid in exchange for the employee's services to the company. Where employees have accrued short-term benefits which the entity has not paid by the balance sheet date, an accrual is recognised within creditors: amounts falling due within one year together with an associated expense in profit or loss. The liabilities are classified as current obligations in the statement of financial position because they are expected to be settled wholly within twelve months after the end of the period.
Foreign currency translation
Transactions in foreign currencies are initially recognised at the rate of exchange ruling at the date of the transaction. At the end of each reporting period foreign currency monetary items are translated at the closing rate of exchange. Non-monetary items that are measured at historical cost are translated at the rate ruling at the date of the transaction. All differences are charged to profit or loss.
Tangible fixed assets and depreciation
All fixed assets are initially recorded at cost. Property, plant and equipment is used in the company's principal activity for the production and supply of goods or for administrative purposes and is stated in the balance sheet under the historic cost model. This model requires the assets to be stated at cost less amounts in respect of depreciation and less any accumulated impairment losses. Depreciation is calculated so as to write off the cost of an asset, less its estimated residual value (which is the expected amount that would currently be obtained from disposal of an asset, after deducting the estimated costs of disposal, if the asset were already of the age and in the condition expected at the end of its useful life), over the useful economic life of the respective asset as follows:

Straight line (years)
Office Equipment3
2.Average number of employees

20232022
Average number of employees during the year128
3.Tangible fixed assets

Office Equipment

Total

££
Cost or valuation
At 01 October 228,6338,633
Additions16,97716,977
Disposals(1,274)(1,274)
At 31 December 2324,33624,336
Depreciation and impairment
At 01 October 224,5154,515
Charge for year6,7186,718
On disposals(106)(106)
At 31 December 2311,12711,127
Net book value
At 31 December 2313,20913,209
At 30 September 224,1184,118
4.Creditors: amounts due within one year

2023

2022

££
Trade creditors / trade payables47,6414,185
Bank borrowings and overdrafts-1,348
Other creditors53,26221,603
Accrued liabilities and deferred income-32,474
Total100,90359,610
5.Creditors: amounts due after one year

2023

2022

££
Other creditors-300,000
Total-300,000